Ovarian Cancer Screening Not Very Effective

| March 04, 2011
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.

Screening for ovarian cancer offers limited value, especially when accounting for the disease's biological diversity, according to a study from the Duke Cancer Institute. Research has shown that ovarian cancer is not a single disease as was previously thought, but rather comprises at least 2 subtypes of varying aggression. The Duke researchers’ computer model predicted that ovarian cancer screening (CA125 and ultrasound) of women aged >50 years would reduce mortality rates by 15% in the single-disease concept and 11% in the 2-subtype model. The percentages vary because the single-disease screening does not account enough for the more aggressive, deadlier tumors. The researchers suggested that, in light of the paltry numbers, preventive measures beyond screening are needed to help control ovarian cancer.



Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.